News
Form 8.3 - The Vanguard Group, Inc.: Tullow Oil plc
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Xcel Energy Third Quarter 2022 Earnings Report
Xcel Energy Inc. (NASDAQ: XEL) today reported 2022 third quarter GAAP and ongoing earnings of $649 million, or $1.18 per share, compared with $609 million, or $1.13 per share in the same period in
![ExxonMobil to Release Third Quarter 2022 Financial Results http://upload.wikimedia.org/wikipedia/commons/1/18/Exxon_Mobil_Logo.svg: By KUsam at en.wikipedia. Later version(s) were uploaded by Cheeselouise at en.wikipedia. [Public domain], from Wikimedia Commons](https://www.sharewise.com/rails/active_storage/blobs/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZWc9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--c4dbe3169ae447c9c41bd56bfd50efcdfdd87d64/Exxon_Mobil_Logo.svg?locale=us){kind=logo}
ExxonMobil to Release Third Quarter 2022 Financial Results
Exxon Mobil Corporation will release third quarter 2022 financial results on Friday, October 28, 2022. A press release will be issued via Business Wire and available at 5:30 a.m. CT at www.exxonmob
Ermenegildo Zegna Group Reports Strong Revenue Growth in Third Quarter of 2022
Ermenegildo Zegna N.V. (NYSE:ZGN) (“Zegna Group,” “the Group,” or “the Company”), owner of the Zegna and Thom Browne brands, today announced unaudited revenues of €357 million for the Third Quarter
Form 8.3 - The Vanguard Group, Inc.: Euromoney Institutional Investor plc
Form 8.3 - The Vanguard Group, Inc.: Countryside Partnerships plc
Form 8.3 - The Vanguard Group, Inc.: Capricorn Energy plc
Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
Form 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
Puma Biotechnology Presents Updated Findings from the Phase II SUMMIT Basket Trial of Neratinib in EGFR Exon 18-Mutant NSCLC at the 2022 EORTC/NCI/AACR Symposium
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, presented updated findings from the Phase II SUMMIT basket trial of neratinib for EGFR exon 18-mutant non-small cell lung
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Ørsted enters into agreement with Equinor on Norwegian gas for Denmark
Ørsted to present results for the first nine month of 2022 on 3 November
Claro Brasil to Extend 4G and 5G-Ready Mobile Services Across Amazon Region with SES’s O3b mPOWER
With unprecedented demand for high-powered mobile connectivity in the most isolated communities of the Amazon, SES today announced it has signed a multiyear capacity renewal with Claro Brasil
EQS-News: First CNS Lymphoma Patient Imaged with PentixaFor in Phase 2 Trial
EQS-News: Medios AG significantly expands compounding capacity at Berlin site – manufacturing permit granted for new laboratory
Eurofins Celebrates 35 Years of Testing for Life and 25 Years as Best Performing Share Listed in Europe
October marks the 35th anniversary of Eurofins (Paris:ERF). Today, the global leader in bio-analysis with 61,000 staff across a network of 940 laboratories in 59 countries, Eurofins’ growth has